A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

Clinical trial NCT04663204 · RECRUITING

Trial details

NCT number: NCT04663204
Sponsor: University of Leicester
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immunoglobulin A Nephropathy Kidney Diseases Glomerulonephritis, IGA Glomerulonephritis Autoimmune Diseases Immune System Diseases

Start date: 2020-12-10
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.